©The Author(s) 2026.
World J Gastroenterol. Jan 14, 2026; 32(2): 114057
Published online Jan 14, 2026. doi: 10.3748/wjg.v32.i2.114057
Published online Jan 14, 2026. doi: 10.3748/wjg.v32.i2.114057
Figure 2 Cedrol attenuated histopathological damage and inflammatory cytokine expression in dextran sulfate sodium-induced colitis.
A: Typical hematoxylin and eosin colon sections (× 100); B: Histopathological scores; C-E: Transcript levels of tumor necrosis factor-alpha (C), interleukin (IL)-1β (D), and IL-6 (E) messenger RNA in colonic tissues were measured by real-time quantitative polymerase chain reaction. Data are presented as mean ± SD (n = 6). aP < 0.05. bP < 0.01. cP < 0.001. CE: Cedrol; DSS: Dextran sulfate sodium; TNF: Tumor necrosis factor; IL: Interleukin; mRNA: Messenger RNA.
- Citation: Zhao YQ, Zhang Y, Qin Y, Zhang RY, Wang JP. Cedrol ameliorates ulcerative colitis via myeloid differentiation factor 2-mediated inflammation suppression, with barrier restoration and microbiota modulation. World J Gastroenterol 2026; 32(2): 114057
- URL: https://www.wjgnet.com/1007-9327/full/v32/i2/114057.htm
- DOI: https://dx.doi.org/10.3748/wjg.v32.i2.114057